The shed P2X7 receptor is an index of adverse clinical outcome in COVID-19 patients
Description
CONCLUSION: Blood sP2X7R was elevated in the early phases of COVID-19 and predicted an adverse clinical outcome. It is suggested that sP2X7R might be a useful marker of disease progression.
